FEATURED

ASH 2016 Live Coverage

Live coverage of the ASH 2016 meeting in San Diego.

Marijuana Legalization in Seven States

CTA spoke with Judith A. Paice, PhD, RN, to better understand how clinicians are reacting to these legalizations and how she responds to patients asking about cannabis use.

Watson: A Glorified Search Engine?

Watson, hoped to be a major source for clinicians, is limited by an inability to interpret clinical trials.

Drugmaker Funding, Rising Drug Prices

Drugmaker funding for patient advocacy groups might be an important but neglected factor in rising drug prices.

TKI-induced Cardiovascular Toxicity in CML

Researchers claim that systems medicine could reduce cardiovascular toxicity caused by TKI therapy.

Precision Medicine in Pediatric Cancer

More research and funding are needed to bring the benefits of precision medicine to pediatric patients.

Lung Cancer: Patients Without Actionable Mutation

Chapter 2: Dr. Levy discusses the treatment of patients in whom there are no targetable mutations.

Strategies in the Management of HER2+

Chapter 4: Drs. Rugo and O’Shaughnessy review the current recommendations for the management of metastatic HER2 positive breast cancer.

New Video Series: Classical Hodgkin Lymphoma

Steven M. Ansell, MD, PhD, of the Mayo Clinic in Rochester, Minnesota

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

Seven States Pass Some Form of Marijuana Legalization

Seven States Pass Some Form of Marijuana Legalization

CTA spoke with Judith A. Paice, PhD, RN, to better understand how clinicians are reacting to these legalizations and how she responds to patients asking about cannabis use.

Watson: A Glorified Search Engine?

Watson: A Glorified Search Engine?

Watson, hoped to be a major source for clinicians, is limited by an inability to interpret clinical trials.

Is Drugmaker Funding for Patient Groups a Hidden Culprit in Rising Drug Prices?

Is Drugmaker Funding for Patient Groups a Hidden Culprit in Rising Drug Prices?

Drugmaker funding for patient advocacy groups might be an important but neglected factor in rising drug prices.

TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia

TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia

Researchers claim that systems medicine could reduce cardiovascular toxicity caused by TKI therapy.

Precision Medicine in Pediatric Cancer

Precision Medicine in Pediatric Cancer

More research and funding are needed to bring the benefits of precision medicine to pediatric patients.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters